Oregon Health & Science University, Portland, Oregon, US.
Wake Forest University School of Medicine, Winston-Salem, North Carolina, US.
Methodist Debakey Cardiovasc J. 2021 Sep 24;17(4):8-14. doi: 10.14797/mdcvj.698. eCollection 2021.
Despite being largely preventable, atherosclerotic cardiovascular disease (ASCVD) continues to be the leading source of morbidity and mortality worldwide. While the past few decades have seen a substantial reduction in ASCVD mortality, much of this is due to significant improvements in treatment of already manifest disease, with its attendant morbidity and impact on quality of life. Moreover, evidence now suggests that ASCVD mortality in the United States has hit a nadir and is likely to start increasing again. It is now time to shift our attention from intervention to prevention. In this review, we explore the tremendous opportunity to define and implement the discipline of preventive cardiology.
尽管动脉粥样硬化性心血管疾病（ASCVD）在很大程度上是可以预防的，但它仍是全球发病率和死亡率的主要原因。尽管在过去几十年中，ASCVD 的死亡率有了显著下降，但这在很大程度上是由于已经出现的疾病的治疗有了重大改善，随之而来的还有发病率和对生活质量的影响。此外，有证据表明，美国的 ASCVD 死亡率已经达到了一个低谷，可能会再次开始上升。现在是时候将注意力从干预转移到预防上了。在这篇综述中，我们探讨了定义和实施预防心脏病学这一学科的巨大机会。
